Decahydroisoquinoline derivatives as novel non-peptidic, potent and subtype-selective somatostatin sst3 receptor antagonists

被引:15
|
作者
Troxler, Thomas [1 ]
Hurth, Konstanze
Schuh, Karl-Heinrich
Schoeffter, Philippe [1 ]
Langenegger, Daniel [1 ]
Enz, Albert [1 ]
Hoyer, Daniel [1 ]
机构
[1] Novartis Inst BioMed Res, Neurosci Dis Area, CH-4002 Basel, Switzerland
关键词
Somatostatin; GPCR; Somatostatin sst(3) receptor; Non-peptidic somatostatin receptor ligands; Subtype-selective sst(3) receptor antagonists; CSF SOMATOSTATIN; BRAIN; IDENTIFICATION; BINDING; GROWTH; SAR;
D O I
10.1016/j.bmcl.2010.01.063
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Starting from non-peptidic sst(1)-selective somatostatin receptor antagonists, first compounds with mixed sst(1)/sst(3) affinity were identified by directed structural modifications. Systematic optimization of these initial leads afforded novel, enantiomerically pure, highly potent and sst(3)-subtype selective somatostatin antagonists based on a (4S,4aS,8aR)-decahydroisoquinoline-4-carboxylic acid core moiety. These compounds can efficiently be synthesized and show promising PK properties in rodents. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1728 / 1734
页数:7
相关论文
共 50 条
  • [41] SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF NOVEL AMIDINE DERIVATIVES AS MUSCARINIC RECEPTOR SUBTYPE-SELECTIVE AGONISTS
    OJO, B
    DUNBAR, PG
    DURANT, GJ
    HUZL, JJ
    ELASSADI, AA
    PERIYASAMY, S
    NGUR, DO
    HOSS, WP
    MESSER, WS
    LIFE SCIENCES, 1995, 56 (11-12) : 1005 - 1005
  • [42] Discovery of 3-Substituted Aminocyclopentanes as Potent and Orally Bioavailable NR2B Subtype-Selective NMDA Antagonists
    Layton, Mark E.
    Kelly, Michael J., III
    Rodzinak, Kevin J.
    Sanderson, Philip E.
    Young, Steven D.
    Bednar, Rodney A.
    DiLella, Anthony G.
    Mcdonald, Terrence P.
    Wang, Hao
    Mosser, Scott D.
    Fay, John F.
    Cunningham, Michael E.
    Reiss, Duane R.
    Fandozzi, Christine
    Trainor, Nicole
    Liang, Annie
    Lis, Edward V.
    Seabrook, Guy R.
    Urban, Mark O.
    Yergey, James
    Koblan, Kenneth S.
    ACS CHEMICAL NEUROSCIENCE, 2011, 2 (07): : 352 - 362
  • [43] Camphor sulfonamide derivatives as novel, potent and selective CXCR3 antagonists
    Wang, Yonghui
    Busch-Petersen, Jakob
    Wang, Feng
    Kiesow, Terence J.
    Graybill, Todd L.
    Jin, Jian
    Yang, Zheng
    Foley, James J.
    Hunsberger, Gerald E.
    Schmidt, Dulcie B.
    Sarau, Henry M.
    Capper-Spudich, Elizabeth A.
    Wu, Zining
    Fisher, Laura S.
    McQueney, Michael S.
    Rivero, Ralph A.
    Widdowson, Katherine L.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (01) : 114 - 118
  • [44] 2-methyl-6-(phenylethynyl)-pyridine (MPEP): A novel potent, subtype-selective and systemically active antagonist at metabotropic glutamate receptor subtype
    Gasparini, F
    Lingenhoehl, K
    Flor, PJ
    Munier, N
    Heinrich, M
    Pagano, A
    Vranesic, I
    Biollaz, M
    Heckendorn, R
    Allgeier, H
    Varney, M
    Johnson, E
    Hess, SD
    Velicelebi, G
    Kuhn, R
    Urban, L
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 : U130 - U130
  • [45] Novel amides as potent and selective histamine H3 receptor antagonists
    Nirogi, Ramakrishna
    Shinde, Anil
    Kambhampati, Ramasastri
    Deshpande, Amol
    Dwarampudi, Adireddy
    Gangadasari, Narsimhareddy
    Cheppala, Atreya
    Rambabu, Namala
    Kandikere, Vishwottam
    Jayarajan, Pradeep
    Muddana, Nageswararao
    Ahmad, Ishtiyaque
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [46] Somatostatin receptor sstl-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands (vol 28, pg 1433, 2001)
    Rebui, JC
    Waser, B
    Schaer, JC
    Laissue, JA
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (09): : 1433 - 1433
  • [47] Antidiabetic activity of a highly potent and selective non-peptidal somatostatin receptor subtype-2 agonist
    Strowski, MZ
    Cashen, DE
    Birzin, ET
    Yang, LH
    Singh, V
    Rohrer, SP
    Smith, RG
    Schaeffer, JM
    DIABETES, 2005, 54 : A411 - A411
  • [48] Identification of the dopamine autoreceptor in the guinea-pig retina as D2 receptor using novel subtype-selective antagonists
    Weber, B
    Schlicker, E
    Sokoloff, P
    Stark, H
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133 (08) : 1243 - 1248
  • [49] Potent and subtype-selective CCK-B/gastrin receptor antagonists: 2,4-dioxo-1,5-benzodiazepines with a plane of symmetry
    Hagishita, S
    Seno, K
    Kamata, S
    Haga, N
    Ishihara, Y
    Ishikawa, M
    Shimamura, M
    BIOORGANIC & MEDICINAL CHEMISTRY, 1997, 5 (07) : 1433 - 1446
  • [50] Novel N1-(benzyl)cinnamamidine derived NR2B subtype-selective NMDA receptor antagonists
    Curtis, NR
    Diggle, HJ
    Kulagowski, JJ
    London, C
    Grimwood, S
    Hutson, PH
    Murray, F
    Richards, P
    Macaulay, A
    Wafford, KA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (04) : 693 - 696